Socio-economic and behavioral determinants of prescription and non-prescription medicine use: the case of Turkey
- 9 Downloads
Demographic and socio-economic factors determine pharmaceutical health care utilization for individuals. Prescription and non-prescription medicine use are expected to have different determinants. Even though prescription and non-prescription medicine use is being well researched for developed countries, there are only a few studies for developing countries.
This paper aims to analyze the socio-economic and individual characteristics that determine the use of prescription and non-prescription medicine. We examine the issue for the specific case of Turkey since Turkey’s health system has undertaken significant changes in the last two decades and especially after 2003 with the “Health Transformation Programme”.
Data from the nationally representative “Health Survey” are used in the analysis. The data set covers the 2008–2016 period with two-year intervals. Pooled multivariate logistic regression is employed to identify the underlying determinants of prescription and non-prescription medicine use.
When compared to 2008, non-prescription medicine use decreases until 2012, however, an increasing trend appears after 2012. For prescription medicine use, a decreasing trend emerges after 2012. Findings from the marginal effects indicate that for non-prescription medicine use, the highest effect stems from the health status. For prescription medicine use, the highest marginal effects arise from age, health and employment status indicating the importance of the need and predisposing factors.
Decreasing non-prescription medicine use largely depends on easier access to health care service utilization. Although having a health insurance has a positive relationship with prescription medicine use, there is still a problem for individuals living a rural area and heaving a lower income level since they are more likely to use non-prescription medicine.
KeywordsPrescription medicine Non-prescription medicine Self-medication Socio-economic determinants Turkey
SÖ and DB are responsible for study design. SÖ performed the data analysis. SÖ, DB, İCÖ and AÖÇ all contributed to writing and correcting the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
Not applicable. The data that support the findings of this study are available from Turkish Statistical Institute but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available.
Consent for publication
All authors give consent for publication.
- 7.OECD, OECD.Stat (database). 2019. https://stats.oecd.org/Index.aspx?ThemeTreeId=9. Accessed 10 August 2019.
- 8.IEIS. Turkish Pharmaceutical Market. 2018. http://ieis.org.tr/ieis/en/sektorraporu2018. Accessed 15 August 2019.
- 9.Daştan, İ., Çetinkaya, V. OECD Ülkeleri ve Türkiye’nin Sağlık Sistemleri, Sağlık Harcamaları ve Sağlık Göstergeleri Karşılaştırması. [Comparing Health Systems, Health Expenditures and Health Indicators in OECD Countries and Turkey] Sosyal Güvenlik Dergisi. 2015; 5(1): 104–134. Turkish.Google Scholar
- 10.OECD. OECD Health Data 2016: Comparative analysis of 30 countries. (Version: 15.06.2017). 2016; OECD, Paris.Google Scholar
- 13.Stokes J, Gurol–Urganci I, Hone T, et al. Effect of health system reforms in Turkey on user satisfaction. J Glob Health. 2015;5(2):1–10.Google Scholar
- 14.Republic of Turkey, Social Security Institution. Social Security System. http://www.sgk.gov.tr/wps/portal/sgk/en/detail/social_security_system (Accessed: 15.03.2019).
- 15.Kartal N, Arısoy S. OTC Grubundaki ilaçların avantaj ve dezavantajlarının incelenmesi. [Examining the advantages and disadvantages of OTC drugs]. Health Care. 2017;4(4):314–21 Turkish.Google Scholar
- 16.Sağır M, Parlakpınar H. Akılcı İlaç Kullanımı. [Rational Drug Use]. Inonu University Journal of Health Sciences. 2014;3(2):32–5 Turkish.Google Scholar
- 21.Pappa E, Kontodimopoulos N, Papadopoulos AA, Tountas Y, Niakas D. Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors. Eur J Clin Pharmacol. 2011;67(2):185–92.PubMedCrossRefGoogle Scholar
- 26.Andersen RM. A behavioural model of families’ use of health services. Chicago: University of Chicago; 1968.Google Scholar
- 29.Makhlouf CO, Schulein M, Kasparian C, Ammar W. Medication use, gender, and socio-economic status in Lebanon: analysis of a national survey. J Med Liban. 2002;5–6(50):216–25.Google Scholar
- 35.Bertakis, K. D., Azari, R., Helms, L. J. et al. Gender differences in the utilization of health care services. J Fam Pract. 2000; 49(2):147–152.Google Scholar